摘要
目的:通过对小儿支原体肺炎的临床治疗措施分析,以期总结一种合理、有效的治疗方案提高临床疗效,促进患儿康复。方法:选取64例小儿支原体肺炎者作为试验组且于同期选取60例小儿支原体肺炎者作为对比研究视为对照组,同时予以两组患儿相应治疗措施且对其临床疗效、临床症状和体征改善时间、治疗时间以及不良事件发生情况予以观察和相关数据的统计学处理分析。结果:试验组临床痊愈率和临床受益率均明显高于对照组,且试验组临床症状、体征改善时间和平均治疗时间较对照组明显缩短,而对照组胃肠道反应和皮疹发生率明显高于试验组(P<0.05)。结论:阿奇霉素序贯疗法是治疗小儿支原体肺炎安全且有效的治疗方案,值得临床推广。
Objective：Clinical analysis of Mycoplasma pneumonia treatment,which summed up a reasonable,effective treatment programs in order to achieve the purpose of improve the clinical efficacy and to promote the rehabilitation of children.Methods：64 cases of mycoplasma pneumonia is selected at the same time as the test group and additional selected in the same period 60 cases of mycoplasma pneumonia as a comparative study as a control group,two groups of children were given the appropriate therapeutic measures and clinical efficacy.improvement in clinical symptoms and signs,duration of treatment,and adverse events were given to observation and data statistical processing and analysis.Results：The experimental group clinical cure rate and clinical benefit rate is significantly higher than that in the control group and the test group of clinical symptoms and signs improved time and the average duration of treatment compared with the control group was significantly shorter and gastrointestinal reactions and rash incidence in the control groupsignificantly higher than the experimental group（P0.05）.Conclusion：Azithromycin sequential therapy as a treatment of mycoplasma pneumonia safe and effective solution is worthy of promotion.
出处
《医学理论与实践》
2012年第23期2868-2869,共2页
The Journal of Medical Theory and Practice
关键词
小儿
支原体肺炎
治疗措施
Mycoplasma pneumonia
Treatment
Analysis
